The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular profiling and potential therapeutic implications of molecular testing utilizing a large database of hepatocellular carcinoma patients.
 
Alexander Hayden
No Relationships to Disclose
 
Vida Alami
No Relationships to Disclose
 
Junxiao Hu
No Relationships to Disclose
 
Christopher Lieu
Consulting or Advisory Role - Flatiron Health (Inst); Pfizer (Inst)
Research Funding - Genentech (Inst)
 
Hannah Robinson
Research Funding - Genentech (Inst)
 
Sunnie Kim
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; BeiGene; Bristol Myers Squibb; Coherus Biosciences; Daiichi Sankyo/Lilly; Gilead Sciences; I-Mab; Jazz Pharmaceuticals; Merck
Research Funding - Merck
 
Alexis Leal
Employment - Elsevier
Leadership - Elsevier
Honoraria - MedPro Specialty Advisory Board
Research Funding - Abbvie (Inst); Antengene (Inst); Arrys Therapeutics (Inst); Bristol-Myers Squibb (Inst); Conjupro Biotherapeutics (Inst); Corcept Therapeutics (Inst); Elicio Therapeutics (Inst); Exelixis (Inst); FameWave Ltd. (Inst); Hutchison MediPharma (Inst); Takeda (Inst)
 
Wells Messersmith
Honoraria - Research to Practice (Inst)
Consulting or Advisory Role - Amgen; Criterium (Inst)
Research Funding - Accent Therapeutics; Agenus (Inst); ALX Oncology (Inst); AstraZeneca/MedImmune (I); Exelixis (Inst); Experimental Drug Development Centre (EDDC); Nurix (Inst); Pfizer (Inst); RasCal (Inst); Revolution Medicines (Inst)
 
Emily Baiyee Toegel
No Relationships to Disclose
 
S. Lindsey Davis
Stock and Other Ownership Interests - Johnson & Johnson/MedTech
Speakers' Bureau - Allergan (I)
Research Funding - Bristol-Myers Squibb (Inst); EMD Serono (Inst); I-Mab (Inst); Merck (Inst); ORIC Pharmaceuticals (Inst); Seagen (Inst); Sensei Biotherapeutics (Inst); Symphogen (Inst); TriSalus Life Sciences (Inst); Tvardi Therapeutics (Inst)